Patients Demand Public Inquiry into NHS Brain Cancer Misdiagnosis Scandal

Patients Demand Public Inquiry into NHS Brain Cancer Misdiagnosis Scandal

Survivors of brain cancer treatment at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are demanding a public inquiry following a review that found patients were severely harmed by years of unnecessary chemotherapy. The investigation, conducted by the Royal College of Physicians (RCP), examined 20 cases under the care of a retired oncologist and determined that some patients were misdiosed or kept on treatment far beyond standard guidelines.

The review found that the chemotherapy drug temozolomide (TMZ), typically administered over six months, was prescribed for many years to some patients. In one instance, a patient received over 100 cycles of the drug over a 13-year period, ultimately developing leukaemia as a side effect. Becky Jones, a mother of two who underwent 11 years of treatment for a cancer she did not have, described the administration of the drug as being “dished out like it was sweets.” She stated that the realization she might have missed key moments in her children’s lives “kills [her] every day.”

According to the report, 83 patients received extended TMZ treatment between 2017 and 2023. Of the 20 cases examined in detail, the RCP concluded that six suffered severe harm, five experienced moderate harm, and eight had low levels of harm. One case could not be assessed for moderate or severe harm. The trust apologized for the “failures” in its neuro-oncology service, with Chief Executive Professor Andy Hardy stating, “We let you down, and for that we offer our sincere apologies.”

The retired doctor, identified in the report as Dr Y and known as Prof Ian Brown, was employed by the trust from 1996 to 2024. Concerns about his practice were raised by colleagues when patients were reassigned following his retirement in late 2023. Dr Brown did not participate in the review and declined to comment when contacted by the BBC. Mark Poulton, another patient who underwent a decade of chemotherapy only to learn in 2024 he had a different type of brain tumor than originally diagnosed, expressed anger at having been “abused by the system.”

Legal firm Brabners, which represents more than 40 patients in claims against the trust, is advocating for an independent statutory public inquiry. The firm noted that while the cases have been referred to the police, no action has yet been taken. UHCW has stated that all living patients currently receiving TMZ have had their care reviewed internally and that an external review will assess all living patients who received more than 12 cycles of the drug under Dr Brown’s supervision. The trust is also in discussions with NHS England regarding how to review the cohort of deceased patients who may have been affected by the non-standard treatment regime.

7 responses to “Patients Demand Public Inquiry into NHS Brain Cancer Misdiagnosis Scandal”

Leave a Reply

Your email address will not be published. Required fields are marked *